Synopsis
0
EU WC
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Neomycin
2. Neomycin Palmitate
3. Neomycin Sulfate
1. Neomycin Sulfate
2. 1405-10-3
3. Neomycin Trisulfate Hydrate
4. Akos016010116
Molecular Weight | 712.7 g/mol |
---|---|
Molecular Formula | C23H48N6O17S |
Hydrogen Bond Donor Count | 15 |
Hydrogen Bond Acceptor Count | 23 |
Rotatable Bond Count | 9 |
Exact Mass | 712.27966526 g/mol |
Monoisotopic Mass | 712.27966526 g/mol |
Topological Polar Surface Area | 436 Ų |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Complexity | 953 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 18 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Neomycin sulfate |
Drug Label | Neomycin Sulfate Tablets, USP, for oral administration, contain neomycin which is an antibiotic obtained from the metabolic products of the actinomycete Streptomycesfradiae. Structurally, neomycin sulfate may be represented as follows:Chemically, i... |
Active Ingredient | Neomycin sulfate |
Dosage Form | Tablet |
Route | Oral |
Strength | 500mg |
Market Status | Prescription |
Company | Oman Pharm Products; Teva; X Gen Pharms |
2 of 2 | |
---|---|
Drug Name | Neomycin sulfate |
Drug Label | Neomycin Sulfate Tablets, USP, for oral administration, contain neomycin which is an antibiotic obtained from the metabolic products of the actinomycete Streptomycesfradiae. Structurally, neomycin sulfate may be represented as follows:Chemically, i... |
Active Ingredient | Neomycin sulfate |
Dosage Form | Tablet |
Route | Oral |
Strength | 500mg |
Market Status | Prescription |
Company | Oman Pharm Products; Teva; X Gen Pharms |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13615
Submission : 1998-09-01
Status : Inactive
Type : II
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-26
Pay. Date : 2013-02-13
DMF Number : 13378
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : R1-CEP 1999-184 - Rev 03
Issue Date : 2020-04-21
Type : Chemical
Substance Number : 197
Status : Valid
Registration Number : 217MF10976
Registrant's Address : 235 East 42nd Street, New York, NY 10017
Initial Date of Registration : 2005-11-14
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32091
Submission : 2017-09-08
Status : Active
Type : II
Certificate Number : R0-CEP 2022-013 - Rev 01
Issue Date : 2023-02-15
Type : Chemical and TSE
Substance Number : 197
Status : Valid
Registration Number : 303MF10156
Registrant's Address : No. 8,Ziyang Road,Dianjun District,Yichang City,HubeiProvince,China
Initial Date of Registration : 2021-10-07
Latest Date of Registration : --
NDC Package Code : 65876-0002
Start Marketing Date : 2017-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 5718
Submission : 2021-10-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 271
Submission : 1940-01-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 124
Submission : 1953-07-23
Status : Inactive
Type : II
NDC Package Code : 0009-5238
Start Marketing Date : 2014-07-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Novartis Korea Ltd.
Registration Date : 2023-08-01
Registration Number : 20230801-211-J-1531
Manufacturer Name : Pharmacia & Upjohn Company LLC
Manufacturer Address : 7000 Portage Road, Kalamazoo, Michigan 49001, USA
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 262
Submission : 1940-01-01
Status : Inactive
Type : II
NDC Package Code : 0009-5238
Start Marketing Date : 2014-07-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Novartis Korea Ltd.
Registration Date : 2023-08-01
Registration Number : 20230801-211-J-1531
Manufacturer Name : Pharmacia & Upjohn Company LLC
Manufacturer Address : 7000 Portage Road, Kalamazoo, Michigan 49001, USA
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
RLD : No
TE Code :
NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
Brand Name : POLY-PRED
Dosage Form : SUSPENSION/DROPS;OPHTHALMIC
Dosage Strength : EQ 0.35% BASE;10,000 UNITS/ML;0.5%
Approval Date : 1982-01-01
Application Number : 50081
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML
Approval Date : 1987-06-11
Application Number : 62788
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE
Dosage Form : OINTMENT;TOPICAL
Dosage Strength : 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM
Approval Date : 1985-09-06
Application Number : 62381
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : NEO-POLYCIN
Dosage Form : SOLUTION/DROPS;OPHTHALMIC
Dosage Strength : 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML
Approval Date : 1982-01-01
Application Number : 60427
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : CORTISPORIN
Dosage Form : OINTMENT;OPHTHALMIC
Dosage Strength : 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 50416
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Brand Name : MYCIFRADIN
Dosage Form : SOLUTION;ORAL
Dosage Strength : EQ 87.5MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 50285
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
Brand Name : NEO-MEDROL ACETATE
Dosage Form : CREAM;TOPICAL
Dosage Strength : 0.25%;EQ 3.5MG BASE/GM
Approval Date : 1982-01-01
Application Number : 60611
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD :
TE Code :
NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : NEOSPORIN G.U. IRRIGANT
Dosage Form : SOLUTION; IRRIGATION
Dosage Strength : EQ 800MG BASE/20ML;4,000,000 UNITS/20ML (EQ 40MG BASE/ML;200,000 UNITS/ML)
Approval Date :
Application Number : 60707
RX/OTC/DISCN :
RLD :
TE Code :
RLD : No
TE Code :
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
Brand Name : NEO-CORTEF
Dosage Form : OINTMENT;TOPICAL
Dosage Strength : 2.5%;EQ 3.5MG BASE/GM
Approval Date : 1982-01-01
Application Number : 60751
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code : AT
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Brand Name : MAXITROL
Dosage Form : OINTMENT;OPHTHALMIC
Dosage Strength : 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
Approval Date : 1982-01-01
Application Number : 50065
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AT
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?